HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Li Selected Research

Ganglionic Blockers

3/2002Sympatholytic therapy in primary hypertension: a user friendly role for the future.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Li Research Topics

Disease

94Neoplasms (Cancer)
05/2021 - 01/2000
20Infections
01/2020 - 08/2000
17Carcinogenesis
02/2021 - 02/2000
14Inflammation (Inflammations)
07/2021 - 01/2003
14Body Weight (Weight, Body)
04/2018 - 04/2000
13Neoplasm Metastasis (Metastasis)
11/2020 - 07/2000
11Breast Neoplasms (Breast Cancer)
01/2020 - 08/2001
10Ischemia
07/2015 - 08/2000
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2008
9Obesity
01/2022 - 12/2000
9Hepatocellular Carcinoma (Hepatoma)
06/2021 - 11/2001
9Hypoxia (Hypoxemia)
01/2020 - 10/2000
8Squamous Cell Carcinoma of Head and Neck
10/2019 - 05/2001
8Carcinoma (Carcinomatosis)
07/2017 - 12/2000
8Fibrosis (Cirrhosis)
02/2017 - 04/2000
8Leukemia
01/2016 - 09/2000
7Multiple Sclerosis
12/2016 - 11/2005
6Insulin Resistance
03/2020 - 01/2011
6Type 2 Diabetes Mellitus (MODY)
09/2018 - 01/2011
6Wounds and Injuries (Trauma)
04/2018 - 11/2000
6Infarction (Infarctions)
01/2018 - 02/2000
6Adenocarcinoma
01/2017 - 03/2000
6Reperfusion Injury
07/2015 - 12/2000
5Port-Wine Stain (Nevus Flammeus)
06/2022 - 09/2013
5Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 12/2001
5Atrial Fibrillation
12/2021 - 07/2000
5Thrombosis (Thrombus)
12/2021 - 04/2000
5Cardiovascular Diseases (Cardiovascular Disease)
10/2020 - 09/2000
5Head and Neck Neoplasms (Head and Neck Cancer)
03/2019 - 05/2001
5Atherosclerosis
05/2018 - 10/2000
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2017 - 07/2001
5Relapsing-Remitting Multiple Sclerosis
04/2013 - 09/2006
4Necrosis
01/2022 - 03/2008
4Asthma (Bronchial Asthma)
05/2021 - 02/2014
4Adenocarcinoma of Lung
05/2021 - 08/2008
4Hemorrhage
09/2020 - 01/2015
4Colorectal Neoplasms (Colorectal Cancer)
07/2020 - 01/2018
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2019 - 08/2001
4Stroke (Strokes)
01/2018 - 08/2000
4Ischemic Stroke
01/2018 - 08/2000
4Fatigue
04/2015 - 04/2002
4Parkinson Disease (Parkinson's Disease)
04/2014 - 01/2006
4Lung Neoplasms (Lung Cancer)
03/2014 - 02/2001
4Graft vs Host Disease (Graft-Versus-Host Disease)
07/2013 - 09/2000
4Heart Failure
01/2013 - 02/2000
3Osteoarthritis
11/2022 - 01/2012
3Pneumonia (Pneumonitis)
05/2021 - 12/2020
3Sepsis (Septicemia)
03/2021 - 09/2000
3Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2020 - 07/2007
3Hypertension (High Blood Pressure)
10/2020 - 08/2015
3Melanoma (Melanoma, Malignant)
05/2020 - 03/2007
3Myocardial Infarction
01/2020 - 03/2002
3Edema (Dropsy)
11/2019 - 09/2014
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

38Proteins (Proteins, Gene)FDA Link
05/2022 - 03/2000
15MicroRNAs (MicroRNA)IBA
05/2022 - 04/2012
13CytokinesIBA
07/2021 - 05/2001
13DNA (Deoxyribonucleic Acid)IBA
07/2021 - 10/2000
13EnzymesIBA
05/2021 - 08/2000
12Biomarkers (Surrogate Marker)IBA
05/2020 - 08/2001
10Messenger RNA (mRNA)IBA
05/2021 - 08/2000
9RNA (Ribonucleic Acid)IBA
06/2020 - 03/2001
9Pharmaceutical PreparationsIBA
01/2020 - 07/2001
9Peptides (Polypeptides)IBA
03/2018 - 01/2000
8Glucose (Dextrose)FDA LinkGeneric
02/2019 - 01/2006
8Indicators and Reagents (Reagents)IBA
08/2018 - 03/2000
7Biological ProductsIBA
09/2020 - 07/2000
7CollagenIBA
02/2017 - 03/2000
6Insulin (Novolin)FDA Link
03/2020 - 05/2013
6AntioxidantsIBA
01/2017 - 10/2000
6AntigensIBA
01/2016 - 01/2001
6DNA AdductsIBA
07/2006 - 04/2000
5LipidsIBA
01/2020 - 05/2001
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2017 - 03/2005
5Transcription Factors (Transcription Factor)IBA
04/2014 - 06/2008
5AntibodiesIBA
04/2014 - 11/2008
4Circular RNAIBA
05/2022 - 01/2020
4ImmunosorbentsIBA
05/2021 - 09/2000
4Cisplatin (Platino)FDA LinkGeneric
01/2021 - 12/2010
4CateninsIBA
01/2021 - 03/2014
4Estrogen ReceptorsIBA
11/2020 - 08/2001
4VaccinesIBA
03/2019 - 03/2007
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2018 - 06/2012
4InterferonsIBA
01/2018 - 09/2006
4InterleukinsIBA
01/2018 - 05/2001
4Phosphotransferases (Kinase)IBA
01/2017 - 08/2008
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017 - 03/2008
4ErbB Receptors (EGF Receptor)IBA
08/2015 - 09/2001
4Laminin (Merosin)IBA
01/2009 - 03/2000
4Losartan (Cozaar)FDA LinkGeneric
06/2001 - 04/2000
4Fibronectins (Fibronectin)IBA
01/2001 - 01/2000
3Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
05/2021 - 06/2012
3Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 07/2001
3Interleukin-17 (Interleukin 17)IBA
07/2020 - 04/2016
3Long Noncoding RNAIBA
05/2020 - 09/2019

Therapy/Procedure

42Therapeutics
10/2019 - 02/2000
8Radiotherapy
06/2021 - 06/2012
8Drug Therapy (Chemotherapy)
07/2020 - 01/2000
6Lasers (Laser)
06/2022 - 09/2013
6Transplantation
02/2013 - 08/2001